G796-0039 Screening compound: 2-{4-[4-(4-methoxyphenyl)piperazine-1-carbonyl]piperidin-1-yl}-6-methyl-1H-1,3-benzodiazole

G796-0039 Screening compound: 2-{4-[4-(4-methoxyphenyl)piperazine-1-carbonyl]piperidin-1-yl}-6-methyl-1H-1,3-benzodiazole
G796-0039 Screening compound: 2-{4-[4-(4-methoxyphenyl)piperazine-1-carbonyl]piperidin-1-yl}-6-methyl-1H-1,3-benzodiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound G796-0039
2-{4-[4-(4-methoxyphenyl)piperazine-1-carbonyl]piperidin-1-yl}-6-methyl-1H-1,3-benzodiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G796-0039

Molecular Formula

C25H31N5O2 (C25 H31 N5 O2)

Compound Name

2-{4-[4-(4-methoxyphenyl)piperazine-1-carbonyl]piperidin-1-yl}-6-methyl-1H-1,3-benzodiazole

IUPAC name

2-{4-[4-(4-methoxyphenyl)piperazine-1-carbonyl]piperidin-1-yl}-6-methyl-1H-13-benzodiazole

SMILES

Cc(cc1)cc([nH]2)c1nc2N(CC1)CCC1C(N(CC1)CCN1c(cc1)ccc1OC)=O

InChI

InChI=1S/C25H31N5O2/c1-18-3-8-22-23(17-18)27-25(26-22)30-11-9-19(10-12-30)24(31)29-15-13-28(14-16-29)20-4-6-21(32-2)7-5-20/h3-8,17,19H,9-16H2,1-2H3,(H,26,27)

InChI Key

PLUHVWDCAKYZNT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15036443

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

433.55

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.781

Distribution Coefficient, logD

3.697

Water Solubility, LogSw

-3.98

Polar Surface Area

49.361

Acid Dissociation Constant (pKa)

14.25

Base Dissociation Constant (pKb)

6.73

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.00

G796-0039 in Drug Discovery

Included in Screening Libraries

CNS targets activity set (6557 compounds)

Human Kinases Annotated Library (2415 compounds)

Protein-Protein Interaction Library (218420 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with G796-0039 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G796-0039?
Check Price and Availability of G796-0039, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G796-0039 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G796-0039
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G796-0039
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G796-0039 available by request